- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Onchocercal Subcutaneous Nodule in United Kingdom
Total 522 results
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingAlpha 1-Antitrypsin DeficiencyUnited Kingdom, United States, Ireland, Belgium, New Zealand, Spain, Netherlands, Portugal, Canada, Australia, France, Austria, Germany, Sweden
-
Mereo BioPharmaSyneos HealthCompletedEmphysema | Alpha 1-Antitrypsin Deficiency | COPDUnited Kingdom, Belgium, United States, Denmark, Canada, Sweden, Poland, Spain
-
Integrated DiagnosticsCompleted
-
Exact Sciences CorporationCompletedLung Cancer (Diagnosis)United States
-
Washington University School of MedicineActive, not recruitingStaphylococcus Aureus | Skin and Subcutaneous Tissue Bacterial Infections | MRSA - Methicillin Resistant Staphylococcus Aureus InfectionUnited States
-
Connie PriceUnited States Department of Defense; Accelerate Diagnostics, Inc.CompletedInfection | Skin and Subcutaneous Tissue Bacterial Infections | Healthcare-associated Infection | Infection Due to Resistant BacteriaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedLung Nodule, Breast, Kidney,Parathyroid, Mediastinal, Skin Mass, Soft Tissue, Prostate, Stomach Pleural, Head and Neck, and Are at Risk of RecurrenceUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedAlpha1-Antitrypsin DeficiencyUnited States, Germany, Canada, Ireland, Sweden, United Kingdom
-
Melinta Therapeutics, Inc.CompletedSkin and Subcutaneous Tissue Bacterial InfectionsUnited States
-
Melinta Therapeutics, Inc.CompletedSkin and Subcutaneous Tissue Bacterial InfectionsUnited States, Croatia, Israel, Latvia, Russian Federation, Spain, Ukraine
-
Denver Health and Hospital AuthorityUnited States Department of Defense; Accelerate Diagnostics, Inc.CompletedSkin and Subcutaneous Tissue Bacterial Infections | Healthcare-associated Infection | INFECTIONS | Infection Due to Resistant BacteriaUnited States
-
University of California, San FranciscoNorthern California Institute of Research and Education; Guardant Health, Inc.RecruitingNon-small Cell Lung Cancer | Nodule Solitary PulmonaryUnited States
-
National Jewish HealthMedical University of South CarolinaUnknownAlpha 1-Antitrypsin DeficiencyUnited States
-
Biocerna LLCCompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
University of FloridaAlpha-1 Foundation; Brantly, Mark L., M.D.CompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
National Center for Research Resources (NCRR)University of PittsburghTerminatedAlpha 1-Antitrypsin DeficiencyUnited States
-
Alpha-1 FoundationRecruiting
-
Medical University of South CarolinaAlpha-1 FoundationCompleted
-
University of FloridaRecruitingAlpha-1 Antitrypsin DeficiencyUnited States
-
Krystal Biotech, Inc.RecruitingAlpha 1-Antitrypsin DeficiencyUnited States
-
Massachusetts Eye and Ear InfirmaryThe Hospital for Sick Children; Medical College of Wisconsin; Drexel University...CompletedVocal Fold NodulesUnited States, Canada
-
University of PennsylvaniaVA Office of Research and DevelopmentCompletedNeoplasms | Adenocarcinoma | Lung and Pleural Malignancies | NodulesUnited States
-
Kamada, Ltd.CompletedAlpha-1 Antitrypsin DeficiencyUnited States
-
University of Massachusetts, WorcesterNational Heart, Lung, and Blood Institute (NHLBI); University of Florida; National... and other collaboratorsCompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
Lu Yuan LeeNational Institute of Allergy and Infectious Diseases (NIAID)WithdrawnPulmonary Atelectasis | Severe Persistent Asthma | Moderate Persistent Asthma | Nodule Solitary PulmonaryUnited States
-
M.D. Anderson Cancer CenterWithdrawnProstate Cancer | Prostate NoduleUnited States
-
Coram Clinical TrialsCompletedAlpha-1 Anti-trypsin DeficiencyUnited States
-
Joseph Dohar, MDRecruitingVocal Fold NodulesUnited States
-
Adverum Biotechnologies, Inc.Completed
-
Kamada, Ltd.CompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
Baxalta now part of ShireArriva Pharmaceuticals, Inc.CompletedAlpha1-antitrypsin DeficiencyUnited States
-
St. Louis UniversityBoston University; University College, London; University of Massachusetts, Worcester and other collaboratorsActive, not recruiting
-
TakedaTakeda Development Center Americas, Inc.RecruitingAlpha1-Antitrypsin DeficiencyUnited States, Belgium, Switzerland, Canada, Australia, Germany, United Kingdom, Austria, France, Spain, Portugal, Italy, Poland
-
University of Massachusetts, WorcesterNational Heart, Lung, and Blood Institute (NHLBI); University of Florida; National... and other collaboratorsCompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
Adverum Biotechnologies, Inc.CompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
Applied Genetic Technologies CorpNational Heart, Lung, and Blood Institute (NHLBI)CompletedAlpha-1 Antitrypsin DeficiencyUnited States, Ireland
-
University of FloridaAlpha-1 FoundationEnrolling by invitation
-
Medical University of South CarolinaNational Center for Research Resources (NCRR); Alpha-1 FoundationCompletedAlpha-1 Antitrypsin DeficiencyUnited States
-
Baxalta now part of ShireTerminated
-
Ankyra Therapeutics, IncRecruitingSolid Tumor | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Malignant Solid Tumor | Cutaneous Tumor | Subcutaneous Tumor | Metastasis to Soft TissueUnited States, Canada
-
Grifols Therapeutics LLCCompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
Baxalta now part of ShireCompleted
-
University of FloridaCompletedAlpha-1 Antitrypsin Deficiency | Liver Fibrosis | AATD | AAT DeficiencyUnited States
-
Baxalta now part of ShireArriva Pharmaceuticals, Inc.CompletedAlpha1-antitrypsin DeficiencyUnited States
-
Grifols Therapeutics LLCCompletedAlpha₁-Antitrypsin DeficiencyUnited States
-
AidenceRecruiting
-
Inhibrx, Inc.RecruitingEmphysema | Alpha 1-Antitrypsin DeficiencyUnited States, Australia, United Kingdom, New Zealand